Aman M. G. et al. (2009)
Journal of the American Academy of Child and Adolescent Psychiatry
48(12), pp. 1143-1154
Arnold L. E. et al. (2012)
Journal of the American Academy of Child and Adolescent Psychiatry
51(11), pp. 1173-1184.
Blankenship K. et al. (2011)
Guanfacine, extended, release, two, patients, pervasive, developmental, disorders
Journal of Child and Adolescent Psychopharmacology
21(3), pp. 287-290
A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.
Journal of Clinical Psychiatry
65(1), pp. 1531-1536
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-90.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-89.
Erickson C. A. et al. (2011)
An open-label naturalistic pilot study of acamprosate in youth with autistic disorder
Journal of Child and Adolescent Psychopharmacology
Erickson C. A. et al. (2010)
Aripiprazole in autism spectrum disorders and fragile X syndrome.
Neurotherapeutics
7(3), pp. 258-263
Erickson C. A. et al. (2005)
Gastrointestinal factors in autistic disorder: a critical review.
Journal of Autism and Developmental Disorders
35(6), pp. 713-727
Kowalski J. et al. (2011)
Paliperidone palmitate in a child with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
October, 21(5), pp. 491-493
McDougle C. J. , Stigler K. A. , Posey D. J. (2003)
Treatment of aggression in children and adolescents with autism and conduct disorder.
Journal of Clinical Psychiatry
64 pp. 16-25
Orsagh-Yentis D. K. et al. (2011)
Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified
Journal of Child and Adolescent Psychopharmacology
Posey D. J. et al. (2008)
Antipsychotics in the treatment of autism.
Journal of Clinical Investigation
118(1), pp. 6-14
Posey D. J. et al. (2006)
The use of selective serotonin reuptake inhibitors in autism and related disorders.
Journal of Child and Adolescent Psychopharmacology
16(1), pp. 181-186
Scahill L. et al. (2012)
Journal of the American Academy of Child and Adolescent Psychiatry
51(2), pp. 136-146